Salarius Pharmaceuticals Inc. (SLRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Salarius Pharmaceuticals ...

    NASDAQ: SLRX · Real-Time Price · USD
    3.79
    -0.16 (-4.05%)
    At close: Sep 26, 2025, 3:58 PM
    3.93
    3.73%
    After-hours: Sep 26, 2025, 07:46 PM EDT

    Salarius Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 1.84M
    Cost of Revenue
    		 4.42K 10.05K 6.68K 19.18K
    Gross Profit
    		 -4.42K -10.05K -6.68K 1.82M
    Operating Income
    		 -5.73M -12.89M -22.98M -12.81M
    Interest Income
    		 158.54K 352.25K 218.73 n/a
    Pretax Income
    		 -5.58M -12.54M -31.61M -12.77M
    Net Income
    		 -5.58M -12.54M -31.37M -12.77M
    Selling & General & Admin
    		 4.96M 5.72K 7.14M 6.1M
    Research & Development
    		 770.03K 7.17K 15.84M 8.55M
    Other Expenses
    		 n/a 12.88M -231 n/a
    Operating Expenses
    		 5.73M 12.89M 22.98M 14.65M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -5.73M 22.95K 22.98M 14.65M
    Income Tax Expense
    		 n/a -12.53M n/a n/a
    Shares Outstanding (Basic)
    		 64.47K 218.73K 142.34K 13.8K
    Shares Outstanding (Diluted)
    		 64.47K 218.73K 142.34K 13.86K
    EPS (Basic)
    		 -86.85 -0.06 -221.55 -930
    EPS (Diluted)
    		 -86.85 -0.06 -221.55 -930
    EBITDA
    		 -5.57M -2.84K -31.6M -12.79M
    EBIT
    		 -5.58M -12.89K -31.61M -12.81M
    Depreciation & Amortization
    		 4.42K 10.05K 6.68K 19.18K

    Add to Watchlist